Search details
1.
Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer.
Br J Cancer
; 119(3): 266-273, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30002437
2.
Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions.
Drug Metab Dispos
; 45(4): 390-398, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28167538
3.
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.
Blood
; 118(17): 4567-76, 2011 Oct 27.
Article
in English
| MEDLINE | ID: mdl-21865346
4.
A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects.
Int J Cancer
; 131(3): E304-11, 2012 Aug 01.
Article
in English
| MEDLINE | ID: mdl-22065400
5.
Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects.
Clin Pharmacol Drug Dev
; 11(1): 100-111, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34242472
6.
Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects.
Br J Clin Pharmacol
; 71(4): 522-7, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21395644
7.
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors.
Clin Cancer Res
; 15(7): 2552-8, 2009 Apr 01.
Article
in English
| MEDLINE | ID: mdl-19318484
8.
Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder.
J Child Adolesc Psychopharmacol
; 30(2): 104-118, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31967914
9.
A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects.
Clin Pharmacol Drug Dev
; 9(3): 307-320, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31777203
10.
A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer.
Clin Cancer Res
; 14(17): 5602-9, 2008 Sep 01.
Article
in English
| MEDLINE | ID: mdl-18765554
11.
Phase I pharmacokinetic/pharmacodynamic study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor tyrosine kinase, in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in first-line treatment of patients with metastatic colorectal cancer.
Clin Cancer Res
; 14(1): 215-23, 2008 Jan 01.
Article
in English
| MEDLINE | ID: mdl-18172273
12.
Retraction notice to "Population pharmacokinetic and pharmacodynamic analysis of bosutinib" [Drug Metab Pharmacokinet 29 (2014) 441-448].
Drug Metab Pharmacokinet
; 34(2): 163, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30922682
13.
Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US Populations.
Clin Pharmacol Drug Dev
; 7(4): 441-450, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29228473
14.
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.
J Child Adolesc Psychopharmacol
; 28(1): 55-65, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29185786
15.
Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.
J Child Adolesc Psychopharmacol
; 28(1): 36-46, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29189044
16.
Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole.
Clin Ther
; 40(5): 733-740, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29703430
17.
Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study.
J Child Adolesc Psychopharmacol
; 28(5): 314-321, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29641237
18.
Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended-Release Oral Suspension for Attention Deficit Hyperactivity Disorder.
Clin Pharmacol Drug Dev
; 6(5): 476-483, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28628269
19.
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.
Clin Pharmacokinet
; 55(10): 1191-1204, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27113346
20.
Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared With Immediate-release Methylphenidate Chewable Tablet.
Clin Ther
; 38(5): 1151-7, 2016 May.
Article
in English
| MEDLINE | ID: mdl-27021606